AH Equity Partners Bio I, L.L.C.

Insider Reports History

Location
Menlo Park, CA
Signature
AH Bio Fund I, L.P. for itself and as nominee for AH Bio Fund I-B, L.P., By: AH Equity Partners Bio I, L.L.C., its General Partner, By: /s/ Scott Kupor, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AH Equity Partners Bio I, L.L.C.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp 10%+ Owner Common Stock 1,579,885 15 Oct 2024 By AH Bio Fund I, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Common Stock 545,454 15 Oct 2024 By AH Bio Fund IV, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Series A Prime Preferred Stock 0 15 Oct 2024 By AH Bio Fund I, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Series B Preferred Stock 0 15 Oct 2024 By AH Bio Fund I, L.P., as nominee

Insider Reports Filed by AH Equity Partners Bio I, L.L.C.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 15 Oct 2024 5 +$7,999,992 4 10%+ Owner 17 Oct 2024, 17:05
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 10%+ Owner 10 Oct 2024, 21:18